Principal Investigator: Mark Mifflin
Keywords: refractive surgery , PRK Department: Ophthalmology-Services
IRB Number: 00099569 Co Investigator: Amy Lin
Specialty: Ophthalmology
Sub Specialties: Refractive Surgery
Recruitment Status: Recruiting

Contact Information

Elizabeth Nuttall

Simple Summary

The study will assess the safety of processed amniotic fluid eyedrops used for 7 days post-operatively by patients undergoing PRK, and evaluate their effects on healing and pain during the post-op period.

Inclusion Criteria

1.      Patients aged 21 years and older

2.      Patients undergoing PRK for visual correction in both eyes.

3.  Willing and able to give consent for study participation and comply with study procedures, including follow up visits.

Exclusion Criteria

  1. Patients with any active eye disease, including keratoconus or any other ectactic disorders

  2. Patients with documented uncontrolled diabetes

  3. Patients with severe dry eye as measure by corneal staining

  4. Patients with calculated PRK treatment resulting in residual stromal bed <300 um

  5. Patients who have had previous eye surgery or refractive laser procedures

  6. Patients with any active collagen vascular disease

  7. Patients who do not have potential of 20/20 or better best-corrected vision in each eye.

Participant Reimbursement

Participants pay a discounted price for the PRK procedure and will receive a $40 to help with transportation to the clinic during the first week of the study.